deltatrials
Completed OBSERVATIONAL NCT04887571

the PrEsentation, Rationale and Impact of reperFUSION for Acute Coronary Syndromes in Cape Town and the Garden Route Health District - the PERFUSION Registry (PERFUSION)

Sponsor: University of Cape Town

Updated 6 times since 2021 Last updated: Jun 23, 2023 Started: Feb 1, 2021 Primary completion: May 31, 2022 Completion: May 31, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Acute Coronary Syndrome and Non ST Elevation Myocardial Infarction, this trial is completed. The trial is conducted by University of Cape Town and has accumulated 6 data snapshots since 2021. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jun 2021 – ~Jun 2022 · 12 months · monthly snapshotRecruiting~Jun 2022 – ~Dec 2022 · 6 months · monthly snapshotRecruiting~Dec 2022 – ~Jul 2023 · 7 months · monthly snapshotCompleted~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jul 2023 — Jul 2024 [monthly]

    Completed

  4. Dec 2022 — Jul 2023 [monthly]

    Completed

    Status: RecruitingCompleted

  5. Jun 2022 — Dec 2022 [monthly]

    Recruiting

Show 1 earlier version
  1. Jun 2021 — Jun 2022 [monthly]

    Recruiting

    First recorded

Feb 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Cape Town
Data source: University of Cape Town

For direct contact, visit the study record on ClinicalTrials.gov .